Tratamento da Leishmaniose tegumentar americana, com les?o em mucosa, por meio do isotionato de pentamidina

摘要

Ten patients with mucosal lesions caused by American tegumental leishmaniasis were treated with pentamidine isothianate at the dose 4 mg/kg on alternate days by the intravenous route. The mean posology was 2,140mg. Healing of the lesions occurred in 9 (90%) of the patients who completed treatment. There was no recurrence during a follow- up time of 1 to 24 months (mean, 7,7 months). One patient discontinued treatment before healing of the lesion because he developed diabetes mellitus. In 3 (30%)patients, blood exams showed increased urea and creatinine levels and leucopenia, which were corrected by increasing the interval between administrations of the drug. Pmtamidine isothianate is efficient in bringing about cicatrization of the lesions but needs further evaluation in terms of its value in preventing recurrence.